ArticleMolecular oncology2022
Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.